These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 24842934)

  • 1. Effect of maternal cardiovascular conditions and risk factors on offspring cardiovascular disease.
    Palinski W
    Circulation; 2014 May; 129(20):2066-77. PubMed ID: 24842934
    [No Abstract]   [Full Text] [Related]  

  • 2. [Perinatal nutrition and hypertension].
    Harder T; Plagemann A
    Klin Padiatr; 2011 Mar; 223 Suppl 1():S1-9. PubMed ID: 21472671
    [No Abstract]   [Full Text] [Related]  

  • 3. Fetal development and risk of cardiovascular diseases and diabetes type 2 in adult life.
    Szostak-Węgierek D; Szamotulska K
    Med Wieku Rozwoj; 2011; 15(3):203-15. PubMed ID: 22006475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Birth characteristics and subsequent risks of maternal cardiovascular disease: effects of gestational age and fetal growth.
    Bonamy AK; Parikh NI; Cnattingius S; Ludvigsson JF; Ingelsson E
    Circulation; 2011 Dec; 124(25):2839-46. PubMed ID: 22124377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal vomiting during early pregnancy and cardiovascular risk factors at school age: the Generation R Study.
    Poeran-Bahadoer S; Jaddoe VWV; Gishti O; Grooten IJ; Franco OH; Hofman A; Steegers EAP; Gaillard R
    J Dev Orig Health Dis; 2020 Apr; 11(2):118-126. PubMed ID: 31474237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiopathology of intrauterine growth retardation: from classic data to metabolomics.
    Dessì A; Ottonello G; Fanos V
    J Matern Fetal Neonatal Med; 2012 Oct; 25(Suppl 5):13-8. PubMed ID: 23025763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart rate variability analysis of normal and growth restricted children.
    Aziz W; Schlindwein FS; Wailoo M; Biala T; Rocha FC
    Clin Auton Res; 2012 Apr; 22(2):91-7. PubMed ID: 22045365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular and metabolic influences of fetal smoke exposure.
    Bakker H; Jaddoe VW
    Eur J Epidemiol; 2011 Oct; 26(10):763-70. PubMed ID: 21994150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-altitude ancestry protects against hypoxia-associated reductions in fetal growth.
    Julian CG; Vargas E; Armaza JF; Wilson MJ; Niermeyer S; Moore LG
    Arch Dis Child Fetal Neonatal Ed; 2007 Sep; 92(5):F372-7. PubMed ID: 17329275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal smoking and infant cardiovascular physiology: a mechanism of early cardiovascular disease development?
    Taylor L; Kelly B; Leeson P
    Hypertension; 2010 Mar; 55(3):614-6. PubMed ID: 20100994
    [No Abstract]   [Full Text] [Related]  

  • 11. Fetal origins of cardiovascular disease.
    Baum M; Ortiz L; Quan A
    Curr Opin Pediatr; 2003 Apr; 15(2):166-70. PubMed ID: 12640273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of maternal heart disease on fetal growth.
    Gelson E; Curry R; Gatzoulis MA; Swan L; Lupton M; Steer P; Johnson M
    Obstet Gynecol; 2011 Apr; 117(4):886-891. PubMed ID: 21422861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shared constitutional risks for maternal vascular-related pregnancy complications and future cardiovascular disease.
    Berends AL; de Groot CJ; Sijbrands EJ; Sie MP; Benneheij SH; Pal R; Heydanus R; Oostra BA; van Duijn CM; Steegers EA
    Hypertension; 2008 Apr; 51(4):1034-41. PubMed ID: 18259037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased elastic tissue defect formation in the growth restricted Brown Norway rat: a potential link between in utero condition and cardiovascular disease.
    Pascoe KC; Wlodek ME; Jones GT
    Pediatr Res; 2008 Aug; 64(2):125-30. PubMed ID: 18391838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Utero Antihypertensive Medication Exposure and Neonatal Outcomes: A Data Linkage Cohort Study.
    Fitton CA; Fleming M; Steiner MFC; Aucott L; Pell JP; Mackay DF; Mclay JS
    Hypertension; 2020 Mar; 75(3):628-633. PubMed ID: 31884860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Birthweight and the future risk of cardiovascular disease: does intrauterine malnutrition have a role in fetal programming?
    Adabağ AS
    J Lab Clin Med; 2001 Dec; 138(6):378-86. PubMed ID: 11753284
    [No Abstract]   [Full Text] [Related]  

  • 17. Fetal alcohol-related growth restriction from birth through young adulthood and moderating effects of maternal prepregnancy weight.
    Carter RC; Jacobson JL; Sokol RJ; Avison MJ; Jacobson SW
    Alcohol Clin Exp Res; 2013 Mar; 37(3):452-62. PubMed ID: 23013325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Dutch Hunger Winter and the developmental origins of health and disease.
    Schulz LC
    Proc Natl Acad Sci U S A; 2010 Sep; 107(39):16757-8. PubMed ID: 20855592
    [No Abstract]   [Full Text] [Related]  

  • 19. Intrauterine growth retardation: characteristics, risk factors and gestational age.
    Callan NA; Witter FR
    Int J Gynaecol Obstet; 1990 Nov; 33(3):215-20. PubMed ID: 1977638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Programming of the stress response: a fundamental mechanism underlying the long-term effects of the fetal environment?
    Phillips DI
    J Intern Med; 2007 May; 261(5):453-60. PubMed ID: 17444884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.